Francesco Tallarico

Francesco Tallarico discloses dealings in Apotex Health Corp. to SEDI. Over a trading history stretching from 9 June 2026 to 1 July 2026, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 19 August 2026: a share grant, in Apotex Health Corp. The median gap between a trade and its publication by SEDI is 9 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.